DE1952407B2 - Mehrphasen lichtbogenschmelzofen - Google Patents

Mehrphasen lichtbogenschmelzofen

Info

Publication number
DE1952407B2
DE1952407B2 DE19691952407 DE1952407A DE1952407B2 DE 1952407 B2 DE1952407 B2 DE 1952407B2 DE 19691952407 DE19691952407 DE 19691952407 DE 1952407 A DE1952407 A DE 1952407A DE 1952407 B2 DE1952407 B2 DE 1952407B2
Authority
DE
Germany
Prior art keywords
melting furnace
arc melting
phase arc
phase
furnace
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19691952407
Other languages
English (en)
Other versions
DE1952407A1 (de
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of DE1952407A1 publication Critical patent/DE1952407A1/de
Publication of DE1952407B2 publication Critical patent/DE1952407B2/de
Withdrawn legal-status Critical Current

Links

Classifications

    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F27—FURNACES; KILNS; OVENS; RETORTS
    • F27D—DETAILS OR ACCESSORIES OF FURNACES, KILNS, OVENS OR RETORTS, IN SO FAR AS THEY ARE OF KINDS OCCURRING IN MORE THAN ONE KIND OF FURNACE
    • F27D11/00—Arrangement of elements for electric heating in or on furnaces
    • F27D11/08—Heating by electric discharge, e.g. arc discharge
    • C—CHEMISTRY; METALLURGY
    • C21—METALLURGY OF IRON
    • C21C—PROCESSING OF PIG-IRON, e.g. REFINING, MANUFACTURE OF WROUGHT-IRON OR STEEL; TREATMENT IN MOLTEN STATE OF FERROUS ALLOYS
    • C21C5/00—Manufacture of carbon-steel, e.g. plain mild steel, medium carbon steel or cast steel or stainless steel
    • C21C5/52—Manufacture of steel in electric furnaces
    • C21C5/5252—Manufacture of steel in electric furnaces in an electrically heated multi-chamber furnace, a combination of electric furnaces or an electric furnace arranged for associated working with a non electric furnace
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F27—FURNACES; KILNS; OVENS; RETORTS
    • F27D—DETAILS OR ACCESSORIES OF FURNACES, KILNS, OVENS OR RETORTS, IN SO FAR AS THEY ARE OF KINDS OCCURRING IN MORE THAN ONE KIND OF FURNACE
    • F27D11/00—Arrangement of elements for electric heating in or on furnaces
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F27—FURNACES; KILNS; OVENS; RETORTS
    • F27D—DETAILS OR ACCESSORIES OF FURNACES, KILNS, OVENS OR RETORTS, IN SO FAR AS THEY ARE OF KINDS OCCURRING IN MORE THAN ONE KIND OF FURNACE
    • F27D3/00—Charging; Discharging; Manipulation of charge
    • F27D3/18—Charging particulate material using a fluid carrier

Landscapes

  • Engineering & Computer Science (AREA)
  • Mechanical Engineering (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Manufacturing & Machinery (AREA)
  • Materials Engineering (AREA)
  • Metallurgy (AREA)
  • Organic Chemistry (AREA)
  • Vertical, Hearth, Or Arc Furnaces (AREA)
  • Furnace Details (AREA)
  • Discharge Heating (AREA)
DE19691952407 1968-10-17 1969-10-17 Mehrphasen lichtbogenschmelzofen Withdrawn DE1952407B2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR170197 1968-10-17

Publications (2)

Publication Number Publication Date
DE1952407A1 DE1952407A1 (de) 1970-08-20
DE1952407B2 true DE1952407B2 (de) 1971-03-11

Family

ID=8655735

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19691952407 Withdrawn DE1952407B2 (de) 1968-10-17 1969-10-17 Mehrphasen lichtbogenschmelzofen

Country Status (10)

Country Link
US (1) US3610795A (de)
JP (1) JPS4829422B1 (de)
BE (1) BE739974A (de)
BR (1) BR6913348D0 (de)
DE (1) DE1952407B2 (de)
ES (1) ES372628A1 (de)
FR (1) FR1601438A (de)
GB (1) GB1252310A (de)
LU (1) LU59646A1 (de)
SE (1) SE364311B (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2632707A1 (de) * 1976-07-21 1978-01-26 Ernst Dipl Ing Beiersdorf Beschickungsanlage an elektro-lichtbogenoefen zur zugabe von legierungsmitteln und zuschlagstoffen

Families Citing this family (120)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3891427A (en) * 1972-10-12 1975-06-24 Lectromelt Corp Method for melting prereduced ore and scrap
SE378735B (de) * 1972-11-17 1975-09-08 Asea Ab
FR2220584B1 (de) * 1973-03-05 1976-05-21 Siderurgie Fse Inst Rech
US3939297A (en) * 1973-12-07 1976-02-17 Chase Brass & Copper Co., Incorporated Stoker feed system
SE7503782L (sv) * 1975-04-02 1976-10-03 Asea Ab Sett och anordning for smeltreduktion av finkornigt jernoxidhaltigt material
US4133967A (en) * 1977-06-24 1979-01-09 The United States Of America As Represented By The Secretary Of The Interior Two-stage electric arc - electroslag process and apparatus for continuous steelmaking
US4447906A (en) * 1981-02-02 1984-05-08 Lectromelt Corporation Arc furnace for producing aluminum
SE8303372L (sv) * 1983-06-14 1984-12-15 Asea Ab Ugnsanordning for smeltning av metaller eller metallegeringar
AT384669B (de) * 1986-03-17 1987-12-28 Voest Alpine Ag Anlage zur herstellung von stahl aus schrott
CA1311787C (en) * 1986-06-24 1992-12-22 Masahisa Tate Method of bottom blowing operation of a steel making electric furnace
FR2705767B1 (fr) * 1993-05-27 1995-07-21 Lorraine Laminage Procédé et installation de production d'acier liquide à partir de matières ferreuses riches en matières carbonées.
DE4339226A1 (de) * 1993-11-15 1995-05-18 Mannesmann Ag Verfahren und Vorrichtung zur Wertstoffgewinnung
AT404841B (de) * 1995-04-10 1999-03-25 Voest Alpine Ind Anlagen Anlage und verfahren zum herstellen von eisenschmelzen
US6673827B1 (en) 1999-06-29 2004-01-06 The Uab Research Foundation Methods of treating fungal infections with inhibitors of NAD synthetase enzyme
US7227011B2 (en) 1998-06-04 2007-06-05 United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention Nucleic acid vaccines for prevention of flavivirus infection
ATE301273T1 (de) * 1999-05-18 2005-08-15 Danieli Technology Inc Elektrischer lichtbogenofen und verfahren zum kontinuierlichen chargieren
EP1702983A3 (de) 2000-04-13 2007-01-10 Medical University of South Carolina Gewebespezifische und pathogenspezifische giftige Verbindungen, Ribozyme, DNAzyme und Antisenseolinukleotide sowie Anwendungen dafür
EP1303502A2 (de) * 2000-07-06 2003-04-23 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Tetrahydrobenzothiazol-analoge als neuroprotektive mittel
WO2002006534A2 (en) 2000-07-17 2002-01-24 Vanderbilt University Method of diagnosing pulmonary hypertension
CA2425779C (en) 2000-10-12 2013-08-06 University Of Rochester Compositions that inhibit proliferation of cancer cells
WO2002081710A1 (en) * 2001-04-06 2002-10-17 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Artificial chromosomes that can shuttle between bacteria, yeast, and mammalian cells
MXPA04003040A (es) * 2001-10-01 2004-07-15 Vanderbil University Uso de inhibidores de calmodulin quinasa ii para tratar la disfuncion miocardica en la enfermedad de corazon estructural.
US20040248289A1 (en) * 2001-10-04 2004-12-09 Vladimir Noskov Tandem repeat markers
KR20100094569A (ko) 2002-02-06 2010-08-26 비코르 테크놀로지스 인코포레이티드 경색방지 분자
ES2384439T3 (es) 2002-06-14 2012-07-04 Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Procedimientos de tratamiento y prevención de colitis que se implican IL-13 y células NK-T
AU2003257181A1 (en) 2002-08-05 2004-02-23 University Of Rochester Protein transducing domain/deaminase chimeric proteins, related compounds, and uses thereof
ES2392511T3 (es) 2002-11-15 2012-12-11 Musc Foundation For Research Development Moduladores de complemento dianas sobre el receptor 2 de complemento
AU2003294462C1 (en) 2002-11-21 2011-06-30 University Of Utah Research Foundation Purinergic modulation of smell
JP2007518422A (ja) 2004-01-21 2007-07-12 ユニバーシティ・オブ・ユタ・リサーチ・ファウンデーション 変異体ナトリウムチャンネルＮａν１．７およびそれに関連する方法
AU2005220874B2 (en) 2004-03-04 2010-12-23 Vanderbilt University Cell-penetrating SOCS polypeptides that inhibit cytokine-induced signaling
US20080166323A1 (en) * 2004-04-14 2008-07-10 Uab Research Foundation Activators of Hexosamine Biosynthesis as Inhibitors of Injury Induced by Ischemia or Hermorrhagic Shock
US20050244335A1 (en) * 2004-05-03 2005-11-03 Rinehart John J Methods and compositions related to increasing antitumor activity of chemotherapeutic agents
CA2566703A1 (en) 2004-05-11 2005-11-24 Vishwa Deep Dixit Methods of inhibiting proinflammatory cytokine expression using ghrelin
EP1773872B1 (de) 2004-05-21 2017-03-15 The Uab Research Foundation Variable lymphozytenrezeptoren, verwandte polypeptide und nukleinsäuren sowie verwendung dafür
EP1811839A4 (de) * 2004-11-18 2008-08-06 Univ Rochester Verfahren und zusammensetzungen in verbindung mit esculentosid a
AU2005319155B2 (en) 2004-12-21 2013-01-31 Musc Foundation For Research Development Compositions and methods for promoting wound healing and tissue regeneration
WO2006113614A2 (en) 2005-04-15 2006-10-26 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Service National Institutes Of Health Methods of treating and preventing inflammatory bowel disease involving il-13 and nkt cells
US7919104B2 (en) 2005-05-19 2011-04-05 The United States Of America As Represented By The Department Of Health And Human Services, Centers For Disease Control And Prevention Functional epitopes of Streptococcus pneumoniae PsaA antigen and uses thereof
US8859585B2 (en) * 2005-05-25 2014-10-14 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Scopolamine for the treatment of depression and anxiety
ES2451667T3 (es) 2005-06-07 2014-03-28 Ocean Nutrition Canada Limited Microorganismos eucariotas para producir lípidos y antioxidantes
US8080534B2 (en) 2005-10-14 2011-12-20 Phigenix, Inc Targeting PAX2 for the treatment of breast cancer
EP2189522A1 (de) 2005-10-14 2010-05-26 MUSC Foundation For Research Development PAX2 als Ziel zur Induktion einer Immunität gegen DEFB1-vermittelte Tumore und bei der Krebstherapie
EP2653542B1 (de) 2005-12-29 2016-06-29 The Regents of The University of California Verfahren und Zusammensetzungen in Verbindung mit mutanter Kunitz-Domäne I von TFPI-2
TWI515007B (zh) 2006-01-05 2016-01-01 美國猶他大學研究基金會 改善以神經系統為標的之藥劑之性質之方法及組合物
US8815804B2 (en) * 2006-02-06 2014-08-26 Sanford-Burnham Medical Research Institute Methods and compositions related to targeting tumors and wounds
US8470965B2 (en) * 2006-03-01 2013-06-25 University Of Utah Research Foundation Methods and compositions related to cyclic peptide synthesis
EP1998792B1 (de) * 2006-03-01 2015-02-18 The University of Utah Research Foundation Verfahren und zusammensetzungen in verbindung mit der synthese zyklischer peptide
US8603751B2 (en) 2006-03-02 2013-12-10 The Uab Research Foundation Mycobacterial disease detection, treatment, and drug discovery
JP5484049B2 (ja) 2006-07-10 2014-05-07 シナプシン ファーマシューティカルズ， インコーポレイテッド 神経学的障害を処置することおよび認知身体能力を強化することにおけるソレノプシンに関する組成物および方法ならびにその使用
AU2007281284A1 (en) 2006-08-02 2008-02-07 The Uab Research Foundation Methods and compositions related to soluble monoclonal variable lymphocyte receptors of defined antigen specificity
EP2560001B1 (de) 2006-09-21 2016-04-13 University of Rochester Zusammensetzungen und Verfahren für eine Proteinverlagerungstherapie für myotone Dystrophie
US8999317B2 (en) 2006-11-01 2015-04-07 University Of Rochester Methods and compositions related to the structure and function of APOBEC3G
CA2672297A1 (en) 2006-12-11 2008-06-19 University Of Utah Research Foundation Compositions and methods for treating pathologic angiogenesis and vascular permeability
EP2101567A4 (de) 2007-01-18 2010-04-21 Univ Utah Res Found Zusammensetzungen und verfahren zur erkennung, behandlung oder prävention von reduktivem stress
EP2596799B1 (de) 2007-02-08 2016-11-23 University of Utah Research Foundation Verfahren und Zusammensetzungen zur Viruseindringungshemmung
WO2008116220A2 (en) 2007-03-22 2008-09-25 Yale University Methods and compositions related to riboswitches that control alternative splicing
CA2685962A1 (en) 2007-05-08 2009-02-05 Burnham Institute For Medical Research Tissue non-specific alkaline phosphatase inhibitors and uses thereof for treating vascular calcification
EP2478766A3 (de) 2007-05-09 2012-08-15 Burnham Institute for Medical Research Wirtsproteinasen als Ziel für eine therapeutische Strategie gegen virale und bakterielle Krankheitserreger
CA2688009C (en) 2007-05-23 2019-04-02 David E. Briles Detoxified pneumococcal neuraminidase and uses thereof
SG174104A1 (en) 2007-05-29 2011-09-29 Univ Yale Riboswitches and methods and compositions for use of and with riboswitches
DK2166845T3 (en) 2007-06-21 2016-02-01 Musc Found For Res Dev ALFA-connexin C-terminal (ACT) peptides FOR THE TREATMENT OF AGE-related macular degeneration
TW200916113A (en) 2007-08-08 2009-04-16 Sod Conseils Rech Applic Method for inhibiting inflammation and pro-inflammatory cytokine/chemokine expression using a ghrelin analogue
US20110081317A1 (en) * 2007-08-08 2011-04-07 University Of Rochester Enhancing Gene Transfer
WO2009042294A2 (en) * 2007-08-10 2009-04-02 Burnham Institute For Medical Research Tissue-nonspecific alkaline phosphatase (tnap) activators and uses thereof
EP2268664B1 (de) 2007-12-03 2017-05-24 The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services Doc1-zusammensetzungen und verfahren zur behandlung von krebs
US20090233993A1 (en) * 2008-03-06 2009-09-17 Burnham Institute For Medical Research Compositions and methods for inhibiting gsk3 activity and uses thereof
WO2009137686A1 (en) 2008-05-08 2009-11-12 University Of Utah Research Foundation Sensory receptors for chronic fatigue and pain and uses thereof
US20090291073A1 (en) * 2008-05-20 2009-11-26 Ward Keith W Compositions Comprising PKC-theta and Methods for Treating or Controlling Ophthalmic Disorders Using Same
WO2010027641A2 (en) * 2008-08-15 2010-03-11 Georgetown University Na channels, disease, and related assays and compositions
EP2370080A1 (de) 2008-12-02 2011-10-05 University of Utah Research Foundation Pde1 als zieltherapeutikum bei herzkrankheiten
US20100286762A1 (en) * 2009-03-18 2010-11-11 Musc Foundation For Research Development Compositions and Methods for Ameliorating Clinical Electrical Disturbances
EP2430161A1 (de) 2009-05-15 2012-03-21 Yale University Gemm-riboswitches, strukturbasierte verbindungskonstruktion mit gemm-riboswitches sowie verfahren und zusammensetzungen zur verwendung von und mit gemm-riboswitches
WO2011020107A2 (en) 2009-08-14 2011-02-17 Georgetown University Compositions and methods for detection and treatment of breast cancer
WO2011022502A1 (en) 2009-08-18 2011-02-24 Georgetown University Boronic acid compositions and methods related to cancer
US20110060000A1 (en) 2009-09-10 2011-03-10 Maurizio Grimaldi Acridine analogs in the treatment of gliomas
WO2011088076A2 (en) 2010-01-12 2011-07-21 Yale University Structured rna motifs and compounds and methods for their use
EP2544715A2 (de) 2010-03-09 2013-01-16 Board Of Regents, University Of Texas System Verfahren und zusammensetzung für chlamydia-antigen zur diagnose und behandlung einer chlamydieninfektion und -erkranung
US20110262347A1 (en) 2010-04-08 2011-10-27 The Salk Institute For Biological Studies Methods and compositions for enhanced delivery of compounds
WO2012021554A1 (en) 2010-08-09 2012-02-16 Yale University Cyclic di-gmp-ii riboswitches, motifs, and compounds, and methods for their use
WO2012082942A2 (en) 2010-12-15 2012-06-21 Neuroadjuvants, Inc. Neuropeptide analogs, compositions, and methods for treating pain
CA2830407C (en) 2011-03-15 2021-08-31 University Of Utah Research Foundation Methods of diagnosing and treating vascular associated maculopathy and symptoms thereof
CA2868735C (en) 2011-03-28 2020-02-25 University Of Utah Research Foundation D-peptide conjugates comprising a membrane localizing potency-enhancing cargo molecule for inhibiting hiv entry
WO2013036636A1 (en) 2011-09-06 2013-03-14 Dana-Farber Cancer Institute, Inc. Compositions and methods of treating cancer
WO2014008475A2 (en) 2012-07-05 2014-01-09 The Ohio State University Compositions and methods related to viral vaccines
WO2014141111A1 (en) 2013-03-14 2014-09-18 Pluristem Ltd. Methods for prevention and treatment of graft-versus-host disease
WO2014201118A2 (en) 2013-06-11 2014-12-18 Sanford-Burnham Medical Research Institute Compositions and methods for targeted endometriosis treatment
EP3711484A1 (de) 2013-07-05 2020-09-23 H. Lee Moffitt Cancer Center And Research Institute, Inc. Lösliches cd33 zur behandlung myelodysplastischer syndrome (mds)
US9884895B2 (en) 2014-03-20 2018-02-06 The University Of North Carolina At Chapel Hill Methods and compositions for chimeric coronavirus spike proteins
US10189878B2 (en) 2014-09-24 2019-01-29 University Of Utah Research Foundation Ebolavirus pre-hairpin intermediate mimics and methods of use
US10376549B2 (en) 2015-01-20 2019-08-13 Adcure Biotechnologies, Llc. Detargeted adenovirus variants and related methods
US10596247B2 (en) 2015-02-20 2020-03-24 Board Of Regents, The University Of Texas System Methods and compositions for attenuated chlamydia as vaccine and vector
US10765754B2 (en) 2015-08-28 2020-09-08 Navigen, Inc. Compositions and methods related to inhibition of respiratory syncytial virus entry
BR112018013872A2 (pt) 2016-01-07 2018-12-18 Navigen Inc inibidores de peptídeo d da entrada do hiv e métodos de uso
US10751340B2 (en) 2016-06-06 2020-08-25 University Of Central Florida Research Foundation, Inc. Combination therapy to improve brain function or promote neurogenesis for treating neurodegenerative conditions
JP2019523008A (ja) 2016-07-29 2019-08-22 オハイオ ステート イノベーション ファウンデーション 腫瘍溶解性ウイルスによるＰＴＥＮ−Ｌｏｎｇの発現
CA3039532A1 (en) 2016-10-05 2018-04-12 University Of Central Florida Research Foundation, Inc. Methods and compositions related to nk cell and anti-pdl1 cancer therapies
EP4215201A1 (de) 2017-03-24 2023-07-26 Ohio State Innovation Foundation Neuartige rekombinante adeno-assoziierte virale vektoren zur einschränkung der off-target-transduktion in der leber und verwendungen davon
ES2963635T3 (es) 2017-03-28 2024-04-01 Ohio State Innovation Foundation Vacunas de péptido PD1 humano y usos de las mismas
US20230140818A1 (en) 2017-04-27 2023-05-04 The University Of Hong Kong Use of hcn inhibitors for treatment of cancer
JP7522426B2 (ja) 2017-05-25 2024-07-25 ユニバーシティ オブ セントラル フロリダ リサーチ ファウンデーション，インコーポレイテッド 天然キラー細胞による殺傷に対する腫瘍細胞の感受性を高めるための新規な腫瘍溶解性ウイルス
US20200225244A1 (en) 2017-09-26 2020-07-16 Sanford Burnham Prebys Medical Discovery Institute Compositions and methods for assessing painful demyelinating and nondemyelinating diseases
CA3085559A1 (en) 2017-12-13 2019-06-20 North Carolina State University Compositions comprising chemotherapeutic agents and checkpoint inhibitors and methods of use
CN112135639B (zh) 2018-04-06 2023-10-20 北卡罗莱纳州立大学 细胞组装介导的癌症免疫治疗检查点抑制剂的递送
US11717551B2 (en) 2018-05-07 2023-08-08 Georgia State University Research Foundation, Inc. Compositions and methods related to Rhamnus prinoides (GESHO) extract for the inhibition of polymicrobial biofilm formation
CA3104664A1 (en) 2018-06-29 2020-01-02 North Carolina State University In situ sprayed bioresponsive immunotherapeutic gel for post-surgical treatment
EP3847650A1 (de) 2018-09-06 2021-07-14 The Broad Institute, Inc. Nukleinsäureanordnungen zur gezielten verabreichung
US11331269B2 (en) 2018-09-06 2022-05-17 Massachusetts Institute Of Technology Methods and compositions targeting lung microbiota and its responding immune pathways for lung cancer treatment
WO2020092057A1 (en) 2018-10-30 2020-05-07 Yale University Compositions and methods for rapid and modular generation of chimeric antigen receptor t cells
US20220136064A1 (en) 2019-02-09 2022-05-05 King Abdullah University Of Science And Technology Compositions and methods for cancer diagnosis and prognosis
US11660330B2 (en) 2019-06-21 2023-05-30 H. Lee Moffitt Cancer Center And Research Institute, Inc. Combination therapy with semaphorin-4D blockade (SEMA4D) and DC1 therapy
US11225508B1 (en) 2020-09-23 2022-01-18 The University Of North Carolina At Chapel Hill Mouse-adapted SARS-CoV-2 viruses and methods of use thereof
JP2023554589A (ja) 2020-11-27 2023-12-28 ジェネラル ナノセラピューティクス エルエルシー 免疫媒介性疾患の治療のための方法及び組成物
US20230279442A1 (en) 2021-12-15 2023-09-07 Versitech Limited Engineered cas9-nucleases and method of use thereof
WO2023173137A1 (en) 2022-03-11 2023-09-14 Yale University Compositions and methods for efficient and stable genetic modification of eukaryotic cells
WO2023220644A1 (en) 2022-05-10 2023-11-16 Yale University Compositions and methods of synthetic ctla-4 tails for reprogramming of car-t cells and enhancement of anti-tumor efficacy
KR20230167924A (ko) * 2022-06-03 2023-12-12 현대제철 주식회사 전기로
WO2024064824A2 (en) 2022-09-21 2024-03-28 Yale University Compositions and methods for identification of membrane targets for enhancement of nk cell therapy
WO2024102997A1 (en) 2022-11-11 2024-05-16 Peterson Jeff R Gout flare prevention methods using il-1β inhibitors
WO2024155821A1 (en) 2023-01-18 2024-07-25 Yale University Chimeric antigen receptors (car) with intrinsically disordered regions and methods of use thereof
WO2024226829A2 (en) 2023-04-26 2024-10-31 Yale University Enpp3-binding molecules, compositions formed therefrom, and methods of use thereof for the treatment of cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US848422A (en) * 1905-06-23 1907-03-26 Frank Wynne Method of maintaining or increasing the fluidity of molten or semimolten materials by means of electricity.
US1339428A (en) * 1916-03-24 1920-05-11 Ludlum Electric Furnace Corp Method of operating an electric furnace

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2632707A1 (de) * 1976-07-21 1978-01-26 Ernst Dipl Ing Beiersdorf Beschickungsanlage an elektro-lichtbogenoefen zur zugabe von legierungsmitteln und zuschlagstoffen

Also Published As

Publication number Publication date
JPS4829422B1 (de) 1973-09-10
SE364311B (de) 1974-02-18
FR1601438A (de) 1970-08-24
BE739974A (de) 1970-03-16
BR6913348D0 (pt) 1973-01-02
LU59646A1 (de) 1970-01-12
DE1952407A1 (de) 1970-08-20
GB1252310A (de) 1971-11-03
US3610795A (en) 1971-10-05
ES372628A1 (es) 1971-11-01

Similar Documents

Publication Publication Date Title
DE1952407B2 (de) Mehrphasen lichtbogenschmelzofen
AT302552B (de) Elektrodenanordnung für Glasschmelzöfen
AT268573B (de) Elektrischer Schmelzofen
IL32254A0 (en) Furnaces
FR1502277A (fr) Four à arc triphasé
CH496364A (de) Symmetrische Mehrphasenschaltung
AT295179B (de) Lichtbogenofen
NO126399C (no) Elektrisk smelteovn.
AT256486B (de) Lichtbogenschmelzofen
AT307573B (de) Wechselstrom-Lichtbogenschweißschaltung
CH499871A (de) Thermischer Schalter
AT266257B (de) Lichtbogenstrahler
AT272552B (de) Elektrischer Glasschmelzofen
FR1503078A (fr) Lance métallurgique
CH496339A (de) Lichtbogenanordnung
AT313153B (de) Vergießbares feuerfestes Material
AT280511B (de) Glasschmelzofen
AT314686B (de) Lichtbogenbrenner
AT292325B (de) Widerstandsbeheizter metallurgischer Schmelzofen
AT296449B (de) Plasmabrenner
AT317567B (de) Plasmalichtbogenofen
FR1460989A (fr) Réfractaire basique
AT285294B (de) Schweißbrenner
DK113800B (da) Kipbar metalsmelteovn.
DE2116117B2 (de) Schmelzofen

Legal Events

Date Code Title Description
E77 Valid patent as to the heymanns-index 1977
EHJ Ceased/non-payment of the annual fee